As for serum NFL, in the large cohort of De Schaepdryver et al. (2020) of 383 ALS patients, those with NFL levels above the median had a HR of 2.21 compared with those with levels below the median. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.